Recombinant Human SYNGR3 Protein，GST

SYNGR3 (Synaptogyrin 3) is a member of the synaptogyrin family of proteins, which are known to be involved in synaptic function and neurotransmitter release in the nervous system. Emerging research has highlighted SYNGR3's role in synaptic plasticity, a fundamental process underlying learning and memory. Dysregulation of SYNGR3 expression has been associated with various neurological disorders, including schizophrenia and autism spectrum disorders, making it a significant focus for studying neurodevelopmental and neuropsychiatric conditions. Moreover, SYNGR3's interactions with other synaptic proteins suggest that it may play a critical role in the formation and maintenance of synapses. The production of recombinant SYNGR3 protein allows researchers to investigate its structural and functional properties in detail, as well as to explore its potential as a therapeutic target. Understanding the mechanistic underpinnings of SYNGR3's function could provide valuable insights into the cellular and molecular bases of synaptic transmission and its implications for brain health and disease. This research is particularly relevant in the context of developing novel strategies for the treatment of related neurological disorders, where therapeutic agents targeting synaptic pathways may offer new avenues for intervention. Thus, the study of SYNGR3 recombinant protein holds promise for enhancing our understanding of neuronal communication and its significance in maintaining cognitive functions.